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ABSTRACT
In addition to the rôle that cytokines (growth factors,
interleukins, instructive factors) play in regulating neuronal
survival, growth and gène expression during development,
récent évidence suggests that thèse intercellular signais can
also control similar functions in the normal, as well as the
injured, adult nervous system. Some of this évidence is
summarized hère, with particular emphasis on the potential
rôle of cytokines in synaptic function and plasticity. A
ICey words : NGF, LIF, TGF, PDGF, IGF, FGF, TNF.
j t is generally accepted that cytokines, acting both
j as permissive growth factors and as instructive
I differentiation factors, can regulate the differentiation
and function of synapses. It may not be as widely
appreciated that the mechanismsand molécules regulating
the development of circuits in the embryonic nervous
system can also influence the flow of synaptic information
in maturity. This is very likely done by modifying the
efficacy of transmission at established connections, and it
may also be accomplished by regulating the rearrangement
of such connections. Proteins and steroids can act
retrogradely as trophic factors, controlling the number of
neurons that innervate a target cell. There is also évidence
that thèse factors can act anterogradely, allowing a neuron
to influence its targets in ways that are not yet fully
understood. Moreover, there is évidence that neurotrophic
factors can be produced by glial and immune cells, as well
as by the neuron itself, acting in an autocrine fashion. In
addition, cytokines can act instructively, to direct neurons
to adopt one or another phénotype. Dramatic changes in
transmitter and associated neuropeptide Systems are known
to occurduringnormal development, and are likely caused
by the ability of instructive neuronal differentiationfactors
to direct gène expression.
Thèse phenomena of plasticity in growth and gène
expression persist into maturity. I review hère some of
the évidence implicatinggrowth and differentiationfactors
in synaptic plasticity and particular behaviors in the
normal, adult organism. Thèse findings contribute to the
growing realization that the adult system is meta-stable,
representing a balance between growth and withdrawal,
gène induction and repression.The évidence also supports
the idea that cytokines are required for maintenance of
the mature system, and that thèse proteins and hormones
could, therefore, be used for therapeutic intervention.
While cytokines are already being tested for their capacity
to rescue dying neurons in human neurodegenerative
diseases, they may also be useful for changing the balance
of transmitter and neuropeptide Systems, and even connec-
tivity, with the goal of modifying behavioral abnormalities.
Trophic and differentiation factors in
development
Many cytokine families, protein and steroid, possess
neurotrophicactivity, supporting survival and growth. The
nerve growth factor (NGF) neurotrophin family is now
composed of at least four members : NGF, brain-derived
neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and
NT-4/5 [1, 2]. Anotheremerging family is the neuropoietic
cytokinegroup, so named for their prominentoverlapping
activities on neural and hematopoietic cells. This family
currently includes the cholinergic neuronal differentiation
factor (CDF;also knovvn as leukemia inhibitory factor, LIF),
ciliary neurotrophic factor (CNTF), oncostatin M (OSM),
growth promoting factor (GPA), and interleukins 6 and
11 (IL-6, 11) [3-5]. Other cytokines with trophic activity
for various neuronal populations include the insulin-like
growth factors (IGFs [6, 7]), fibroblastgrowth factors (FGFs
[8-10]), platelet-derived growth factors (PDGFs [11-13]),
and membersofthe transforming growth factorsuperfamily
(TGFs [14-16]). Gonadal as well as corticosteroids and
ecdysteroids also regulate neuronal survival and growth
[17-20].
It is striking that trophic factors, even those within a
single family, can act on partially overlapping populations
of neurons [21]. While responsivity to the various
family members is determined by which neurotrophin or
neuropoieticcytokine receptor, for instance, is expressed
on a neuron's surface, thèse receptorsoften do not display
absolute specificity for the various members of the family
[22-26].The meaningof this phenomenon for development
is not yet clear. Another emerging gêneralization is that
many or ail of the trophic proteins can be produced by
neuronsas well as glia, peripheral tissues and immune cells
[27]. Moreover, steroids can be produced by peripheral
tissues as well as the nervous system [28, 29]. Thèse
findings indicate thattrophic factors may function in modes
other than as traditional, target-derived, rétrograde agents.
An antérograde action for trophic factors is suggested by
findings with bFGF in the visual system. This protein is
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synthesizedand released by retinal cells in vivo [30], and
it can be anterogradely transported by retinal ganglion
neurons to their target sites in the latéral geniculate body
and the superior colliculus [31]. There is also évidence that
the neurotransmitter vesicles of adrenal chromaffin cells
may contain bFGF [32, 33]. Moreover, preliminary reports
indicate that neurotrophicactivity is released from thèse
cells when they are depolarized [34, 35]. Chromaffin cells
also contain several TGF-fJsand a CNTF-like trophic factor
[35]. Since chromaffin cells resemble neurons in many
respects, and neurons themselves produce neurotrophic
factors [36-38], it seems highly likely that thèse factors
are used in the nervous system in both the antero-
and rétrograde directions. There is ample évidence that
antérograde influences can regulate neuronal survival
and gène expression during development [39, 40]. It is
also worth noting that nonneuronal target tissues express
receptors for neurotrophicfactors [38, 41].
The finding that a neuron can express receptorsfor a factor
that it produces suggestsan autocrineor even an intracrine
rôle. In fact, sensory, sympathetic, motorand hippocampal
pyramidal neurons express cognate trophic factor and
receptor mRNAs [21]. Glia have long been thought to
provide support for neurons,and the localizationof trophic
factor mRNAsto such cells has bolsteredthis view [42, 43].
It should be pointed out, however, that the prédominant
site of expression for several trophic factors in the intact
brain is in neurons [36, 44-47]. The rôle of immune cells
in the trophic contextwill be considered below.
In addition to supporting the survival and growth of
neurons, many of thèse factors have been shown to
regulate the expression of spécifie sets of neuronal gènes
duringdifferentiation.The gènes for neurotransmittersand
neuropeptidesallow a particular neuron to be recognized
by this set of phenotypic markers. The neuropoietic
cytokines have been intensively studied in this regard,
particularly with sympathetic neurons as the target cell
[5, 27, 48]. In addition, activin A, a member of the TGF
superfamily, induces a différent, but partially overlapping
set of gènes when compared to the neuropoieticcytokines
in the cultured sympathetic neuron assay [48]. Activin
A can also mimic a target-derived factor that induces
expression of the neuropeptide somatostatin (SOM) in
cultured ciliary ganglion neurons [49]. Moreover, activin
A mRNA is found in cells cultured from this target
(the choroid [49]). In addition, BDNF can selectively
induce the expression of the neuropeptides SOM and
neuropeptide Y (NPY) in cultures of rat cortical neurons,
without affecting neuronal survival in this population [50].
Similarly, NGF can selectively induce the expression of
particularneuropeptides in sensory neurons [51].
Growth and differentiation factors in the
adult nervous system
Growthand differentiationfactors are active in the normal,
undamaged, adult nervous system, and they are involved
in the response to injury as well. It is clear that the adult
nervous system existe in a state of dynamic equilibrium[52]. Denervation of adult skeletal muscle or blocking
activity induced by the nerve, for example, causes a
séries of changes in the myotubes that can be viewed
as a return to an embryonic, preinnervation state. When
nerves subsequently reinnervate the myotubes, a séquence
of changes that were seen in development unfolds once
again, producing a mature muscle. Thus, the state of
differentiation of the muscle is plastic, and dépends on
its innervation [52, 53].
Similar plastic phenomena are observed in the nerve
fibers themselves when imbalances are introduced
experimentally [52, 53]. In partially denervated muscles,
the remaining, intact axons sprout and innervate the
denervated myotubes. An activity-based mechanism can
be invoked hère as well, because sprouting can also
be induced by blocking nerve-muscle transmission or
paralyzing the muscle, and electrical stimulation of the
muscle preventssprouting induced by partial denervation.
Thèse and other results illustrate that the mature nerve-
muscle system is in a state of dynamic balance.
Similar phenomena have been observed in neuron-neuron
synapses. Intact, undisturbed neuron-neuron and neuron-
muscle junctions in the adult mammal display continuai
sprouting of small axonal and dendritic branches, parts of
postsynapticgutters are vacated, and newsynaptic contacts
are formed [54, 55].
Sprouting from intact synapses can be evoked in the
adult by administration of trophic factors such as IGF-2
and CNTF [56, 57]. NGF continues to be synthesized in
adult peripheral tissues and retrogradely transported by
mature sensory neurons [58-60]. In addition, injection of
antibodies to trophic factors into adult animais can induce :
régressive changes in sensitive neuronal populations [61-
64], and NGF administration to adult rats affecte the
physiological properties of nociceptive sensory neurons
[65]. Injection of NGF into brains of aged rats can
improve spatial memory, without affecting the number of
NGF-receptor-positive neurons in the nucleus basalis [66].
Qualitativeas well as quantitativeaspects of neuronal gène
expressionare also in a state of flux in maturity. Continued
présence of neuropoietic and neurotrophic factors is
required for maintenance of neuropeptide expression by
cultured peripheral and central nervous system (CNS)
neurons [67]. Rerouting of axons to novel targets in
the adult rat can alter neuropeptide phénotype as well
[68]. Conversely, perturbation of normal neuronal activity
can regulate neurotrophicfactor expression. For example,
blockade of nicotinic, cholinergic activity can up-regulate
BDNF and NGF mRNA in the adult hippocampus
[69]. In addition, the balance between the activity of
the glutaminergic and •y-aminobutyric acid Systems can
regulate the level of BDNF and NGF mRNA in this
structure [70]. In the visual system, physiological variations
in sensory stimulation can induce dramatic changes in
BDNF expression in adult rat visual cortex [71]. Light-
evoked activity can control the growth and sprouting of
axons in the visual cortex, and administration of NGF can
prevent the shift in ocular dominance normally observed
in monocularly-deprivedrate and cats [72].
Neuropoietic cytokines may also be involved in the
régulation of thèse phenomena. For instance, CDF/LIF
and its receptor mRNA levels are highest in the visual
cortex and hippocampus, reaching maximal values in
adulthood [73-76]. Moreover, mice in which the CDF/LIF
gène has been disrupted by homologous recombination
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display severe altérations in neuronal organization and
phénotypes in the hippocampus and visual cortex [77]. It
is not yet known, however, whether thèse altérations occur
during developmentor in maturity. It is clear that the adult
sensory cortex is capable of enormous plasticity,displaying
major changes in sensory maps very quickly [78]. It will be
of great interest to see what rôle trophic and differentiation
factors play in thèse remarkable changes.
Steroids are another key group of trophic and differen-
tiation factors active in the CNS. In addition to their
organizationaleffectson the embryonicbrain [19], gonadal
steroids can regulate neuropeptide expression in the adult
CNS independently of effects on neuronal survival and
growth. Estrogen controls the differential expression of
cholecystokinin (CCK) and substance P (SP) mRNAs in
a sexually dimorphic pathway in the amygdala [79-80].
The instructive nature of this régulation is particularly
striking because thèse two neuropeptides are co-expressed
in the same neurons. The physiological nature of this
action is evidenced by the variation in the number
of CCK-positive neurons during the estrous cycle [81].
The variation in CCK content makes it likely that the
character of the synaptic transmission between this subset
of estrogen-sensitive neurons in the amygdala and their
target cells in the preoptic area is altered during the
estrous cycle. Such altérations have been termed "chemical
switching" of transmission by thèse cells [82, 83]. Another
striking example of this phenomenon is the differential
régulation of galanin (GAL) and lutenizing hormone
releasing hormone (LHRH) in neurons that express both
neuropeptides simultaneously [84]. In addition, estradiol
can alter neuronal circuitry very rapidly. In the 24 h period
between proestrous and estrous, for example, synaptic
density in the CA1 région of the hippocampus déclines
about a third [85], a resuit consistent with changes in
synaptic density evoked by expérimental manipulationsin
hormone levels [86].
In the paraventricular nucleus of the hypothalamus,
glucocorticoid hormone exerts a sélective, négative
feedback on the expressionof corticotropin-releasingfactor
(CRF) and vasopressin (VP), without affecting levels of
enkephalinand neurotensin [83]. CRF mRNA levels follow
the diurnal surge in corticostérone, and adrenalectomy
results in higherCRF and a massive increasein VP [87, 88].
Independent control of the 8 différent neuropeptides in
thèse neurons may reflect the fact that thèse neurons
are thought to form various synapses with différent
functions as their axons traverse the hypothalamus,
médian eminence and anterior pituitary [83]. The three
physiological conditions of chronically low, médium and
high circulatingcorticostérone would yield paraventricular
neurons of three distinct chemical states. This steroid, in
its neuronal differentiation factor rôle, could thus alter
synaptic function in an anatomically stable circuit that
is the final common pathway for mediating the pituitary-
adrenal response to stress, on a minute-to-minute time
scale [88].
Glucocorticoids may also act indirectly to alter neuronal
gène expression. For example, corticostérone (as well as
testosterone)can regulate NGF expression, in neurons and
astrocytes [89, 90]. This hormone can also inhibit the
production of CDF/LIF by heart cells and non-neuronal
cells of sympathetic ganglia [91-92]. This régulation can
alter the phénotype of neurons cultured with such non-
neuronal cells.
Another aspect of cytokine action in the adult nervous
system is the response to injury. Wounds in the CNS
or interruption of a peripheral nerve results in the
upregulation of many growth and differentiation factors,
including CDF/LIF, NGF, TGF-B1 and glial maturation
factor B [1, 76, 93-95]. Tumor necrosis factor a (TNFa),
IL-1a, FGF and epidermal growth factor (EGF) have
similarly been implicated in the response to nerve injury[94, 96-102]. Although the interplay of thèse signaling
agents with neurons, glia and immune cells is not well
understood as yet, damaged neurons may participate
in feedback loops involving trophic and differentiation
factors. For example, transecting postganglionic nerves
or culturing sympathetic ganglia for 24 h induces the
neuropeptides vasoactive intestinal polypeptide (VIP), SP
and galanin (GAL) [103-106; M. Rao, J. L. Escary, Y. Sun,
J. Perreau, P. H. Patterson, R. E. Zigmond, P. Brulet,
and S. C. Landis, submitted]. It is notable that the
neuropoieticcytokines can induce the same neuropeptides
in sympathetic neurons. Moreover, transection of thèse
nerves or culturing the ganglia evokes an enormous rise in
CDF/LIF mRNA [76]. Linking thèse observations is the
récent finding that sympathetic ganglia from CDF/LIF-
deficient mice do not display this striking increase in
VIP and GAL expression upon explantation to culture or
axotomy (M. Rao, J. L. Escary, Y. Sun, J. Perreau, P. H.
Patterson, R. E. Zigmond, P. Brulet, and S. C. Landis,
submitted). Thus, CDF/LIF médiates a major part of the
neuropeptide induction that occurs in response to injury.
Why is neuropeptide phénotype altered when sympathetic
neurons are damaged ? One possibility is that the
neuropeptides play a trophic rôle. Tissue injury and
inflammation,for instance, alter neuronal gène expression
through enhanced nociceptor activity, and the induced
neuropeptides and excitatory amino acids are thought
to be involved in the axonal sprouting and plasticity
associated with thèse injuries, and with nerve damage
[107, 108]. Another possibility is that the neuropeptides
can act on immune cells. A SP antagonist can act as
a potent inhibitor of neurogenic inflammation [109]. In
the case of sympathetic neurons, it may be important to
alter the neuropeptides the neurons are producing. Local
release of CDF/LIF would induce sympathetic neurons
to produce neuropeptides known to attract and activate
immune cells (VIP and SP) [110, 111]. There is évidence
that sympathetic axons participate in the inflammation
associated with arthritis [112]. A rôle for CDF/LIF in the
nervoussystem injury response fits nicelywith its proposed
functions in the hematopoieticand hepatic responses to
infection [113].
Synaptic plasticity
A major feature of the issues considered thus far is that
dynamicaltérations in transmitter/neuropeptide expression
can occur in mature neurons.This response can be a resuit
of normal fluctuations in neuronal activity or hormone
levels, or in response to injury. Thèse changes in neuronal
gène expressioncan entaiI qualitativechanges in the mode
of synaptic transmission (e.g. chemical switching), and are
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likely to influencethe behaviors associatedwith the estrous
cycle, for instance.
Altérations in synaptic transmission are also believed to
be central to the complex events comprising learning
and memory. Long-term potentiation (LTP) of synaptic
efficacy is one ofthe most inténsivelystudied mechanisms
in this regard [114]. Are cytokines involved in LTP and
similar types of synaptic plasticity ? Clearly, neurotrophin
expression can be regulated by neuronal activity on a
time scale of hours [70, 115-118]. Moreover, a stimulus
paradigm used to induce LTP in hippocampal slices
increases BDNF and NT-3 mRNAs [119]. Stimulation of
intact neocortex releases heat-labile factors that enhance
neurite outgrowthfrom PC12 cells and induce LTP in slices
of hippocampus [120]. The LTP-inducing activities in the
cortical superfusate are heterogeneousin size, rangingfrom
<3 to >50 kD [121]. The high molecularweight fraction
induces LTP soon after its application, while the smaller
fractions require 50 min to induce potentiation. Thèse
résulte suggest that diverse molécules and mechanisms
are involved.
Known cytokines and their antagoniste are also being
tested in LTP assays. In hippocampalslices, EGF and FGF
enhance potentiation of the population spike amplitude
and field excitatory posteynaptic potential slope in the
CA1 région [122, 123]. Thèse effects are observed at
6-60 ng/ml of cytokine [124]. The action of the two
cytokines is distinct; enhancement of LTP by EGF is
greater in the earlier phase, while the effect of FGF is
greater in the later phase [123, 124]. Thèse time periods
correspond to the induction and maintenance phases of
LTP. Cytokine administration can also be effective in
the living animal. EGF and FGF, but not NGF, increase
the magnitude and probability of LTP induction in the
dentate gyrus of the intact hippocampus [125]. The
mechanism of LTP facilitation by EGF is being pursued
in dissociated hippocampal neurons. Using the fura-2
assay, EGF and bFGF are found to significantly enhance
the intracellular calcium increase induced by N-methyl-
D-aspartate (NMDA; a glutamate analog) [126, 127].
Thèse results suggest that both proteins selectively enhance
NMDA receptor-mediated responses in hippocampal
neurons, an effect that could contribute to the facilitation
of LTP by thèse cytokines.
In contrast to the effects of EGF and FGF, IL-1B induces
synaptic inhibition in rat hippocampal pyramidal neurons
[128]. This resuit could be due to the inhibitory function of
SOM, which can be induced by IL-1B in the cortex [129].
lnterferon and IL-2 can suppress previously established
LTP as well as its induction in the hippocampus [130,
131]. TNF-a can affect LTP an hour after its addition to
hippocampal slices [132].
The relatively rapid effects of the cytokines in thèse
assays raise the question of whether they can influence
intercellular signaling directly, rather than through the
altération of gène expression. Many cytokine receptors
have tyrosine kinase domains [133], and electrophysiolog-
ical and genetic évidence implicate protein kinases in LTP
[134-136]. Thus, cytokines could indeed act directly as
neuromodulators or neurotransmitters.
It is also possible that cytokine-driven changes in gène
expression may be involved in learning and memory.
Long-term changes in synaptic efficacy involve RNA and
protein synthesis, and there is évidence that some aspects
of LTP may also require new protein synthesis [137]. In
fact, cytokines can induce major changes in neuropeptide
expression rather quickly; 20-fold increases in S.P and V4P
mRNAs were observed in sympathetic ganglia within 24 h[138]. Thus, the instructive actions of cytokines could be
involved in relativelyshort-term synaptic plasticity,as well
as in the consolidationphase of memory or its conversion
from short- to long-term storage. An intriguing corrélation
in this respect is the récent finding that one of the gènes
induced in the hippocampaldentate gyrus by the glutamate
analog kainate is MyD118, a gène that is also induced by
CDF/LIF and IL-6 in myeloidcells [139]. If nothingelse, this
finding suggests common signaling pathways for cytokine
action and activity involved in long term plasticity.
Another point at which cytokines could influence learning
is in the morphological changes that can accompany
learning and related behavioral paradigms. It is now clear
that anatomical connections are continuaily remodeled in
adult as well as developingnervous Systems, and some of
thèse changes can be linked directly to learning [53, 140-
144]. A particularly intriguing example in this context are
the structural changes that accompany long-term synaptic
facilitation in Aplysia. In this case, growth of presynaptic
processes requiresthe présenceofthe posteynapticneuron,
suggesting the action of a retrogradely acting trophic factor
[145-147]. Once more, the suggestion is that the same
developmental mechanismsemployedto set up the wiring
system can be used in the mature brain to modify thèse
connections [148].
Perspectives
It is clear that cytokines can act as neuronal trophic
and differentiation factors, and that thèse agents are
probably utilized in both the rétrogradé and antérograde
directions. There are newly emerging familiesof cytokines
and receptors that, along with other superfamilies, are
involved in 1) the response to injury, and the feedback
between the immune and nervous Systems, 2) the ongoing
functions of the organism, 3) the changes in synaptic
plasticity involved in learning and memory, and 4)
possibly in synaptic transmission directly. The ability to
regulate neuropeptide expression, both qUantitatively and
qualitatively, adds another dimension to the plasticity
and capacity for change that is becoming clear from
expérimental manipulations of the CNS. This régulation
can dramatically alter synaptic function, both rapidly, in
short-term physiological assays, or over the course of a
day or month. Thèse changes in synaptic function appear
to contribute in key ways to complex animal behaviors,
such as estrous, the stress response, and possibly circadian
rhythms. While évidence is accumulatingithat cytokines
may be involved in expérimental paradigms of learning
and memory, it is not yet clear if this involvement is in
the context of neurotransmitter/neuropeptide régulation,
physical rearrangement of synaptic contacts, or through
direct action on membrane tyrosine kinases and signal
cascades. Another frontief is the potential use of cytokines
in the treatment of pathological conditions in the
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nervous system. Clinical trials are underway to test the
efficacy of thèse agents in the neurotrophic context
where neurons are dying, but they could also prove
useful in the manipulation of transmitter/neuropeptide
imbalances in mental disorders. Moreover, genetic testing
for prédisposition to particular conditions could open
the way for early, prophylactic intervention with thèse
factors. T
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